000			01729 a2200481 4500
005			20250513194750.0
264		0	_c19991202
008			199912s 0 0 eng d
022			_a0008-5472
040			_aNLM _beng _cNLM
100	1		_aShaheen, R M
245	0	0	_aAntiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. _h[electronic resource]
260			_bCancer research _cNov 1999
300			_a5412-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aApoptosis
650	0	4	_aColonic Neoplasms _xdrug therapy
650	0	4	_aEndothelium _xdrug effects
650	0	4	_aFluorescent Antibody Technique
650	0	4	_aIn Situ Nick-End Labeling
650	0	4	_aIndoles _xpharmacology
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aNeovascularization, Pathologic _xdrug therapy
650	0	4	_aPyrroles _xpharmacology
650	0	4	_aRandom Allocation
650	0	4	_aReceptor Protein-Tyrosine Kinases _xdrug effects
650	0	4	_aReceptors, Growth Factor _xdrug effects
650	0	4	_aReceptors, Vascular Endothelial Growth Factor
650	0	4	_aTumor Cells, Cultured
700	1		_aDavis, D W
700	1		_aLiu, W
700	1		_aZebrowski, B K
700	1		_aWilson, M R
700	1		_aBucana, C D
700	1		_aMcConkey, D J
700	1		_aMcMahon, G
700	1		_aEllis, L M
773	0		_tCancer research _gvol. 59 _gno. 21 _gp. 5412-6
999			_c10510583 _d10510583